The store will not work correctly when cookies are disabled.
US9162991, 4n
ID: ALA3889690
PubChem CID: 25053577
Max Phase: Preclinical
Molecular Formula: C19H16N4O4
Molecular Weight: 364.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(Cn2cc(C(=O)/C=C/c3ccc([N+](=O)[O-])cc3)nn2)cc1
Standard InChI: InChI=1S/C19H16N4O4/c1-27-17-9-4-15(5-10-17)12-22-13-18(20-21-22)19(24)11-6-14-2-7-16(8-3-14)23(25)26/h2-11,13H,12H2,1H3/b11-6+
Standard InChI Key: XQUIQFOPFXYYED-IZZDOVSWSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.5956 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2526 1.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2524 0.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4979 -1.0529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0317 -0.7359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.7433 0.3919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.2371 1.4856 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.6194 -0.8266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1129 -0.6780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.9891 -1.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.4819 -1.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.3552 -2.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.7355 -4.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.2427 -4.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3695 -3.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.6067 -5.5580 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-13.1095 -6.6501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-14.8012 -5.4430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
10 13 1 0
13 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
23 25 2 0
6 26 1 0
26 27 2 0
27 3 1 0
M CHG 2 23 1 24 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.36 | Molecular Weight (Monoisotopic): 364.1172 | AlogP: 3.14 | #Rotatable Bonds: 7 |
Polar Surface Area: 100.15 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.28 | Np Likeness Score: -1.38 |
References
1. (2015) Cinnamoyl inhibitors of transglutaminase, |